42 results
424B5
ICON Operational Financing Unlimited Co
26 Apr 24
Prospectus supplement for primary offering
9:41am
mission is to improve the lives of patients by accelerating the development of our customers’ drugs and devices through innovative solutions.
We … organizations. Our mission is to improve the lives of patients by accelerating the development of our customers’ drugs and devices through innovative
F-3ASR
Pharmaceutical Research Associates, Inc.
26 Apr 24
Automatic shelf registration (foreign)
8:19am
through innovative solutions.
Our service offering includes clinical development, functional outsourcing and laboratory services. Our clinical
6-K
EX-99.1
ICLR
Icon Plc
21 Feb 24
ICON Reports Fourth Quarter and Full Year 2023 Results
4:31pm
December 31, 2023.
CEO, Dr. Steve Cutler commented, “With our focus on delivering innovative clinical development solutions, ICON’s solid performance
6-K
EX-99.1
ICLR
Icon Plc
9 Jan 24
Icon PLC 6-K
8:15am
execution for our customers. We remain focused on driving efficiency in clinical trials through investments in automation, innovative tools
6-K
EX-99.3
0k41hgundlfb t788l3
12 Jun 23
Notice of Annual General Meeting
8:07am
6-K
EX-99.1
g9nc om07gq
16 May 23
Icon PLC 6-K
6:15am
6-K
EX-99.1
hd5xagdwh4uzc un
6 Sep 22
Icon PLC 6-K
4:30pm
6-K
EX-99.3
e7103gtrtrpctod7soh0
17 Jun 22
Notice of Annual General Meeting
9:12am
6-K
EX-99.1
lcfnbbj acczyx
22 Feb 22
Icon PLC 6-K
7:45am
6-K
EX-99.1
c46le
21 Jul 21
Icon PLC 6-K
4:20pm
6-K
EX-99.3
u9r9p35 3pwf7yksdb
16 Jun 21
Notice of Annual General Meeting
4:16pm
425
gzvjn5o2lucy 9s8u01s
17 May 21
Business combination disclosure
9:00am
425
9h3qiv5
11 May 21
Business combination disclosure
5:06pm
6-K
EX-99.1
pa4a8v 5m
28 Apr 21
Icon PLC 6-K
4:15pm
425
a7rc5ldw781st2ogmurz
20 Apr 21
Business combination disclosure
1:30pm
425
u0dmaqy9mo6qs8uvj1
1 Apr 21
Business combination disclosure
12:00am
425
twmnnv
26 Feb 21
Business combination disclosure
12:00am
425
EX-99.1
mwbdi udzk
24 Feb 21
Business combination disclosure
5:23pm